BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18069898)

  • 1. A mechanism misregulating p27 in tumors discovered in a functional genomic screen.
    Garrett-Engele CM; Tasch MA; Hwang HC; Fero ML; Perlmutter RM; Clurman BE; Roberts JM
    PLoS Genet; 2007 Dec; 3(12):e219. PubMed ID: 18069898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma.
    Kuppers DA; Hwang HC; Jackson AL; Linsley PS; Clurman BE; Fero ML
    PLoS One; 2011 Mar; 6(3):e14758. PubMed ID: 21412408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
    Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
    Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
    Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
    J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.
    Hwang HC; Martins CP; Bronkhorst Y; Randel E; Berns A; Fero M; Clurman BE
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11293-8. PubMed ID: 12151601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity.
    McArthur GA; Foley KP; Fero ML; Walkley CR; Deans AJ; Roberts JM; Eisenman RN
    Mol Cell Biol; 2002 May; 22(9):3014-23. PubMed ID: 11940659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p27Kip1 gene transcription by mitogens.
    Bagui TK; Cui D; Roy S; Mohapatra S; Shor AC; Ma L; Pledger WJ
    Cell Cycle; 2009 Jan; 8(1):115-24. PubMed ID: 19158484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV latent membrane protein 2A orchestrates p27
    Fish K; Sora RP; Schaller SJ; Longnecker R; Ikeda M
    Blood; 2017 Dec; 130(23):2516-2526. PubMed ID: 29074502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
    Shin S; Steffen DL
    Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
    Pippa R; Espinosa L; Gundem G; García-Escudero R; Dominguez A; Orlando S; Gallastegui E; Saiz C; Besson A; Pujol MJ; López-Bigas N; Paramio JM; Bigas A; Bachs O
    Oncogene; 2012 Sep; 31(38):4207-20. PubMed ID: 22179826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
    Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
    Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Cell Flow-Mediated Quiescence Is Temporally Regulated and Utilizes the Cell Cycle Inhibitor p27.
    Tanke NT; Liu Z; Gore MT; Bougaran P; Linares MB; Marvin A; Sharma A; Oatley M; Yu T; Quigley K; Vest S; Cook JG; Bautch VL
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1265-1282. PubMed ID: 38602102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.
    Martins CP; Berns A
    EMBO J; 2002 Jul; 21(14):3739-48. PubMed ID: 12110586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression.
    Jin X; Jin X; Sohn YW; Yin J; Kim SH; Joshi K; Nam DH; Nakano I; Kim H
    Cancer Lett; 2013 Jan; 328(2):235-42. PubMed ID: 23022473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
    Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
    Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S; Raven JF; Koromilas AE
    Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.
    Orlando S; Gallastegui E; Besson A; Abril G; Aligué R; Pujol MJ; Bachs O
    Nucleic Acids Res; 2015 Aug; 43(14):6860-73. PubMed ID: 26071952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.